The RE1-silencing transcription factor (REST, also known as NRSF) is a master repressor of neuronal gene expression and neuronal programmes in non-neuronal lineages [1] [2] [3] . Recently, REST was identified as a human tumour suppressor in epithelial tissues 4 , suggesting that its regulation may have important physiological and pathological consequences. However, the pathways controlling REST have yet to be elucidated. Here we show that REST is regulated by ubiquitin-mediated proteolysis, and use an RNA interference (RNAi) screen to identify a Skp1-Cul1-F-box protein complex containing the F-box protein b-TRCP (SCF b-TRCP ) as an E3 ubiquitin ligase responsible for REST degradation. b-TRCP binds and ubiquitinates REST and controls its stability through a conserved phospho-degron. During neural differentiation, REST is degraded in a b-TRCP-dependent manner. b-TRCP is required for proper neural differentiation only in the presence of REST, indicating that b-TRCP facilitates this process through degradation of REST. Conversely, failure to degrade REST attenuates differentiation. Furthermore, we find that b-TRCP overexpression, which is common in human epithelial cancers, causes oncogenic transformation of human mammary epithelial cells and that this pathogenic function requires REST degradation. Thus, REST is a key target in b-TRCP-driven transformation and the b-TRCP-REST axis is a new regulatory pathway controlling neurogenesis.
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REST levels decline during differentiation of embryonic stem cells to neural stem and progenitor cells 5 , consistent with a role for REST in restraining neuronal gene expression programmes. This decrease results from a threefold reduction in REST half-life (Fig. 1a) , suggesting that a regulatory pathway controls REST degradation during early neural differentiation. To determine whether ubiquitination is involved, REST was evaluated for ubiquitin modification in vivo. Immunoprecipitation of HA-ubiquitin revealed slower migrating species of REST, suggestive of polyubiquitination (Fig. 1b, lane 3) . REST also precipitated with an HA-ubiquitin mutant lacking all lysines except K48 (Fig. 1b, lane 4) , suggesting that REST is K48 polyubiquitinated which promotes degradation.
To search for the E3 ubiquitin ligase for REST, we began with the SCF superfamily of ligases 6 . Each SCF family contains a unique Cullin scaffold that is required for ligase function. Notably, co-expression of a dominant negative Cullin-1 (Cul1) mutant resulted in a dramatic increase (11-fold) in REST levels (Supplementary Figure 1b) , indicating that one or more Cul1-containing ligases negatively regulate REST abundance.
F-box proteins act as substrate receptors for the SCF 7, 8 . To determine which F-box proteins are required for REST turnover, we established a system for monitoring REST abundance in a highthroughput manner using an mRFP-REST fusion protein. Like endogenous REST, mRFP-REST was unstable, and its abundance increased upon inhibition of Cul1 ( Supplementary Fig. 2a ). To identify the F-box proteins regulating REST, individual short interfering RNA (siRNAs) targeting each F-box protein (four siRNAs per gene) were co-transfected with a plasmid encoding mRFP-REST, and changes in cellular fluorescence were monitored by flow cytometry ( Supplementary Fig. 2b ). siRNAs that increased fluorescence more than two standard deviations from the mean were re-tested in triplicate for their effects on both mRFP and mRFP-REST to identify siRNAs that specifically alter REST stability (Fig. 1c) . This approach identified FBW4 and b-TRCP2. Notably, multiple siRNAs targeting additional sequences within FBW4 and b-TRCP2 also increased mRFP-REST abundance (Fig. 1d) , confirming the specificity of the siRNAs. Supporting this conclusion, co-expression of a dominant negative b-TRCP mutant (lacking the F-box) also increased REST levels ( Supplementary Fig. 4a, b) .
b-TRCP2 and FBW4 may control REST abundance by direct ubiquitination of REST or by modulating upstream regulators of REST. b-TRCP2, but not FBW4, was capable of binding REST in cells (Fig. 1e) , suggesting that FBW4-mediated regulation is indirect. The highly homologous b-TRCP1 also interacted with REST ( Fig. 1e and Supplementary Fig. 3a) , consistent with previous reports that b-TRCP1 and b-TRCP2 have similar substrate specificities and frequently function redundantly 9, 10 . Importantly, endogenous b-TRCP and REST interact in cells ( Supplementary Fig. 3b ), and REST was polyubiquitinated by SCF b-TRCP1 in vitro (Fig. 1f) , suggesting that SCF b-TRCP regulates REST by direct ubiquitination. In agreement, stable expression of short-hairpin RNAs (shRNAs) targeting b-TRCP1 and b-TRCP2 both in human mammary epithelial cells (HMECs) and NIH3T3 cells resulted in a moderate but reproducible increase in REST protein abundance and half-life (Fig. 1g , lanes 2 and 3, and Supplementary Fig. 4c ), indicating that endogenous REST is regulated by b-TRCP. These data indicate that SCF b-TRCP controls REST by ubiquitin-mediated destabilization. SCF b-TRCP binds substrates in a phosphorylation-dependent manner 6, [10] [11] [12] [13] [14] . Consistent with this, l-phosphatase treatment abolished the interaction between REST and b-TRCP, and this was prevented by l-phosphatase inhibitors (Fig. 2a) . Notably, a dominant negative frame-shift mutant of REST found in human colon cancer cells 4 failed to interact with b-TRCP and exhibited substantially increased stability in cells ( Supplementary Fig. 6a ), indicating that the carboxyterminal half of REST is required for b-TRCP recognition. Analysis of this region revealed a sequence highly similar to the phospho-degron found in Cdc25A, a well-documented b-TRCP-substrate 11, 12 (Fig. 2b ). This putative degron includes a conserved DpSG motif that constitutes a critical interaction element within phospho-degrons for b-TRCP
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. Mass spectrometry was used to examine phosphorylation of REST within this region. To enable tryptic digestion of the peptide of interest, a N1022R substitution was introduced into REST that does not alter interaction with b-TRCP or protein stability in cells ( Supplementary  Fig. 5a, b) . His-tagged REST N1022R was co-expressed with dominantnegative Cul1 in 293T cells and purified under denaturing conditions ( Supplementary Fig. 5c ). Analysis of phosphopeptides in REST N1022R demonstrated that S1027 and S1030 within the MSEGSDDSGLHG-ARPVPQESSR peptide are phosphorylated both singly and in combination ( Supplementary Fig. 5c-g ).
To test the ability of the candidate REST-degron to interact with b-TRCP, peptides spanning the degron were synthesized with phosphates at serines 1024, 1027 and 1030 alone or in combination. Individual serine-phosphorylation facilitated weak (S1030) or no interaction (S1024 or S1027) with b-TRCP ( Fig. 2d and Supplementary Fig. 7 ) whereas peptides phosphorylated in combination at S10271S1030 or S10241S10271S1030 associated with b-TRCP (but not FBW4) with an efficiency comparable to the well-established IkB phospho-degron peptide ( Fig. 2d and Supplementary Fig. 7 ). Mutation of each serine to alanine in the context of full-length REST resulted in decreased binding to b-TRCP, and combined mutation of these critical serines completely abrogated the interaction with b-TRCP ( Fig. 2c and Supplementary Fig. 6b ). Notably, degronmutant REST was substantially more stable than wild-type REST in cells (Fig. 2e) . These data support the hypothesis that phosphorylation of the REST degron primes ubiquitination by SCF b-TRCP , thereby promoting REST degradation.
The role of b-TRCP in degradation of the REST tumour suppressor predicts that b-TRCP overproduction might transform human cells. To examine this prediction, HMECs stably expressing shRNA: S-b-TRCP1 was transcribed/translated in vitro and incubated with biotin-conjugated peptides spanning the REST degron (unphosphorylated or phosphorylated) or the IkB degron (phosphorylated). Peptide-associated proteins were precipitated with streptavidin-conjugated beads, analysed by SDS-polyacrylamide gel electrophoresis (SDS-PAGE), and quantified using a phospho-imager. Peptide sequence spanning the REST degron is shown in the top panel. e, 293T cells expressing wild-type or degron-mutant Flag-REST complementary DNAs (cDNAs), were examined for Flag-REST protein halflife in a cycloheximide (Chx) timecourse.
human telomerase catalytic subunit (hTERT) and the SV40 LT oncogene ('TLM-HMECs' 16 ) were transduced with a control or GFP-b-TRCP1-expressing retrovirus. Stable ectopic expression of b-TRCP1 resulted in reduced REST abundance (Fig. 3a) and robust anchorageindependent proliferation (Fig. 3b) , thus phenocopying REST lossof-function 4 . This is consistent with a transgenic mouse model in which ectopic b-TRCP1 expression in the mammary gland produced advanced breast cancer 17 . To determine whether REST degradation is critical for b-TRCP1-mediated transformation, TLM-HMECs stably expressing b-TRCP1 were transduced with retroviruses expressing wild-type or degron-mutant REST. Exogenous REST expression did not alter proliferation on an adhesive cell culture surface (Fig. 3c) . In contrast, b-TRCP1-induced anchorage-independent proliferation was severely impaired by restoring REST expression (Fig. 3d) . Consistent with its increased stability, degron-defective REST suppressed b-TRCP1-transformation more efficiently (Fig. 3d and Supplementary Fig. 8 ). These data implicate REST as an essential target in b-TRCP-driven oncogenic transformation.
Although REST is a well-documented regulator of neuronal gene expression and has been proposed to restrain several steps in neurogenesis (reviewed in ref. 3) , its role in neurogenesis has not been tested genetically. Thus, we used embryonic stem cells to examine genetically the roles of REST and b-TRCP in the differentiation programme of neural stem and progenitor cells (reviewed in ref. 18 ). For this we employed embryonic stem cells in which eGFP was recombined into the Sox1 locus 19, 20 ('46c cells'), a well-characterized marker of early neural differentiation in vitro and in vivo.
We first confirmed that endogenous REST stability is regulated during neural differentiation of 46c cells. As shown in Fig. 4a , REST half-life declined twofold in differentiated cells, consistent with the decreased REST stability observed in homogeneous neural stem cells (Fig. 1a) . This decrease may be driven, in part, by a concomitant 13-fold increase in b-TRCP1 expression (Fig. 4b) . To test the role of REST and b-TRCP in this differentiation programme, 46c cells were transfected with control, REST or b-TRCP1-targeting siRNAs alone or in combination, and subsequently cultured in differentiation Note: in this experiment, exogenous REST was expressed at levels higher than endogenous REST. f, 46C cells from e were cultured in N2B27 differentiation medium and analysed for Sox1:GFP fluorescence. This experiment was performed in sextuplicate (error bars 6 s.d.) and is representative of two independent experiments. g, Embryonic stem cells were infected as in e, differentiated into the neural lineage using an embryoid body-retinoic acid protocol, and analysed for Sox1 mRNA by qRT-PCR (normalized to GAPDH mRNA abundance). Experiment was performed in triplicate (error bars 6 s.d.).
media and analysed for neural differentiation by flow cytometric analysis of Sox1:eGFP fluorescence. Inactivation of REST promoted differentiation, correlating with the efficiency of REST knockdown ( Fig. 4c and Supplementary Fig. 10a, b) , thus providing the first genetic evidence that REST negatively regulates early neural differentiation. Conversely, siRNAs that suppress b-TRCP1 expression more than 90% ( Supplementary Fig. 11c ) attenuate differentiation into the neural lineage (Fig. 4c) . These results were confirmed in multiple time points (data not shown) and with multiple siRNAs ( Supplementary Fig. 10b, d) . Importantly, simultaneous REST1b-TRCP1 knockdown increased Sox1:eGFP-positive cells more than fivefold relative to b-TRCP1-siRNA alone (Fig. 4c) , showing REST reduction restores neural differentiation in the absence of b-TRCP. Similar results were observed by measuring the abundance of an independent neuronal marker, TUBB3 (Fig. 4d) . Thus, downregulation of REST is a critical function of b-TRCP during early neural differentiation.
These data support the model that b-TRCP regulates neural differentiation by facilitating REST degradation and predicts that a nondegradable REST would impede neural differentiation. To test this, we first examined the stability of wild-type or degron-mutant REST expressed in the context of neural differentiation. In this experiment, REST transgenes were expressed at levels much lower than endogenous REST to prevent alterations in differentiation kinetics (see below). Notably, the stability of endogenous REST and wild-type exogenous REST decreased similarly during neural differentiation ( Supplementary Fig. 10e and Fig. 4a ). In contrast, degron-mutant REST was stable, regardless of the cellular differentiation status (Supplementary Fig. 10e ). To test whether REST stabilization alters neural differentiation, 46c cells were transduced with high-titre retroviruses expressing wild-type or degron-mutant REST, resulting in a 1.5-and 2.6-fold increase in total REST (Fig. 4e) . Notably, both transgenes attenuated neural differentiation, with the degronmutant REST eliciting a more dramatic phenotype (Fig. 4f) .
To demonstrate REST's role in neural differentiation further, we used an independent neural differentiation assay. Embryonic stem cells stably expressing wild-type or degron-mutant REST were differentiated by formation of embryoid bodies followed by stimulation with retinoic acid, a protocol routinely used to differentiate embryonic stem cells into the neuronal lineage 21 . In this context, nondegradable REST suppressed differentiation more than fivefold as measured by messenger RNA (mRNA) expression of Sox1 (Fig. 4g) . Collectively, these observations strongly link b-TRCP function and REST degradation in controlling neural differentiation.
Here we demonstrate that REST is a labile protein targeted for ubiquitin-dependent proteasomal degradation by SCF b-TRCP through a phospho-degron on REST. We show SCF b-TRCP is a critical regulator of both physiological and pathological REST activities, constituting a new pathway controlling neural differentiation and cellular transformation (see Supplementary Fig. 11 ). We provide the first genetic evidence that REST and SCF b-TRCP regulate an early stage in neural specification. Our data are consistent with a model in which developmental cues induce degradation of REST, resulting in the de-repression of proneural REST targets. The ability of REST to inhibit terminal differentiation of neurons also predicts that it may promote proliferative properties in the neuronal lineage when overproduced or inappropriately stabilized. Consistent with this notion, REST is overexpressed in human medulloblastoma, and ectopic REST expression in v-myc-immortalized neural stem cells promotes medulloblastoma formation in mice 22, 23 . Thus, the contrasting roles of REST as an oncogene and tumour suppressor are highly dependent on the developmental lineages.
b-TRCP is overexpressed and oncogenic in epithelial cancers 17, 24, 25 , and we identified REST as a key target in this context. This suggests that pharmacological inhibition of b-TRCP may provide a way of restoring REST tumour suppressor function in human cancer. The presence of a phospho-degron motif within REST suggests a role for upstream kinase(s) and/or phosphatase(s) that control REST degradation. We propose a model in which differentiation into the neural state is induced by this yet to be discovered signal transduction cascade that targets REST for degradation by SCF b-TRCP , acting cooperatively with induction of b-TRCP expression during neural differentiation. Conversely, hyperactivation of such pathway(s) priming REST degradation may be oncogenic in epithelial tissues and thus serve as new therapeutic targets in cancers with compromised REST function. Thus, exploration of these pathways will probably provide new opportunities for modulating neural stem-cell and cancer-cell behaviour.
METHODS SUMMARY
siRNA screen. For the initial F-box siRNA screen, 272 siRNAs targeting 68 unique F-box proteins 26 (four siRNAs per F-box gene) were arrayed individually in 96-well format. 293T cells were transfected with 100 nM siRNAs using oligofectamine under standard conditions. On the subsequent day, cells were transfected with CMV-mRFP-REST plasmid DNA using mirus Trans-IT 293 under the manufacturer's recommended conditions. Cells were analysed for mRFP fluorescence after 48 h by flow cytometry. Subsequent testing of all candidate siRNAs was performed in triplicate and normalized to effects on mRFP (two independent experiments). Neural differentiation. 46C embryonic stem cells were induced to differentiate by culture in serum-free N2B27 medium (1:1 ratio of DMEM/F12 and Neurobasal medium, supplemented with N2 and B27 (Invitrogen)). For embryoid body formation, cells were plated in Corning ultra-low attachment six-well plates at 5 3 10 5 cells per well in embryonic stem medium without LIF. Medium was changed every two days, and retinoic acid was added from day 4 to day 8 to 1 mM final concentration. Transformation assays. Retroviral infections of HMECs were performed with indicated viral supernatants in the presence of 8 mg ml -1 polybrene, and transduced cells were selected for resistance to the appropriate drug: puromycin (2.0 mg ml -1 ), neomycin (200 mg ml -1 ). Anchorage-independent proliferation assays were performed as previously described 4 . For each assay, the average of at least three replicates 6 s.d. is shown.
Full Methods and any associated references are available in the online version of the paper at www.nature.com/nature.
